UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061916
Receipt number R000070842
Scientific Title Fluid retention after ingestion of sucrose- and isomaltulose-containing beverages at low-to-moderate carbohydrate concentrations
Date of disclosure of the study information 2026/06/15
Last modified on 2026/06/15 16:58:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The Effects of Low-Carbohydrate Beverage Ingestion on Fluid Retention responses

Acronym

Low-Carbohydrate Beverage and Hydration Responses

Scientific Title

Fluid retention after ingestion of sucrose- and isomaltulose-containing beverages at low-to-moderate carbohydrate concentrations

Scientific Title:Acronym

Low-Carbohydrate Beverage and Hydration Responses

Region

Japan


Condition

Condition

NA

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The present study aimed to investigate the effects of sucrose- and isomaltulose-containing beverages at low-to-moderate carbohydrate concentrations (i.e., 1.5%, 4.0%, and 6.5%) on fluid-retention responses in healthy young adults at rest.

Basic objectives2

Others

Basic objectives -Others

NA

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Total urine volume, beverage hydration index, and plasma volume

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Water : Participants consume 1 L of water over 30 min. After ingestion, participants rest in a seated or semi-recumbent position for 3 h. Each trial is separated by at least 7 days. Participants complete the water, sucrose, and isomaltulose trials in a randomized crossover order within each carbohydrate concentration condition; not all participants complete all three carbohydrate concentration conditions.

Interventions/Control_2

Sucrose-containing beverage: Participants consume 1 L of a sucrose-containing beverage over 30 min. The sucrose concentration is 1.5%, 4.0%, or 6.5%. After ingestion, participants rest in a seated or semi-recumbent position for 3 h. Each trial is separated by at least 7 days. Participants complete the water, sucrose, and isomaltulose trials in a randomized crossover order within each carbohydrate concentration condition; not all participants complete all three carbohydrate concentration conditions.

Interventions/Control_3

Isomaltulose-containing beverage: Participants consume 1 L of an isomaltulose-containing beverage over 30 min. The isomaltulose concentration is 1.5%, 4.0%, or 6.5%. After ingestion, participants rest in a seated or semi-recumbent position for 3 h. Each trial is separated by at least 7 days. Participants complete the water, sucrose, and isomaltulose trials in a randomized crossover order within each carbohydrate concentration condition; not all participants complete all three carbohydrate concentration conditions.

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

40 years-old >

Gender

Male and Female

Key inclusion criteria

Young healthy adults

Key exclusion criteria

1: Smokers and obese individuals
2: Individuals with a history of heart disease
3: Individuals with arrhythmia
4: Individuals with a history of bronchial asthma
5: Individuals with a history of gastrointestinal disorders
6: Individuals with epilepsy
7: Individuals taking medication for chronic conditions or other illnesses
8: Individuals who have previously experienced vagal nerve reflex associated with needle puncture
9: Individuals unable to draw their own blood
10: Individuals deemed ineligible by the principal investigator

Target sample size

36


Research contact person

Name of lead principal investigator

1st name Tatsuro
Middle name
Last name Amano

Organization

Niigata University

Division name

Faculty of Education

Zip code

950-2181

Address

8050 Igarashi-Ninocho, Nishiku, Niigata

TEL

0252627161

Email

amano@ed.niigata-u.ac.jp


Public contact

Name of contact person

1st name Tatsuro
Middle name
Last name Amano

Organization

Niigata University

Division name

Faculty of Education

Zip code

950-2181

Address

8050 Igarashi-Ninocho, Nishiku, Niigata

TEL

0252627161

Homepage URL


Email

amano@ed.niigata-u.ac.jp


Sponsor or person

Institute

Niigata University

Institute

Department

Personal name

Tatsuro Amano


Funding Source

Organization

Mitsui DM Sugar Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Human Ethics Committee of Niigata University

Address

8050 Igarashi-Ninocho, Nishiku, Niigata

Tel

025-227-2625

Email

ethics@adm.niigata-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

新潟大学教育学部(新潟県)


Other administrative information

Date of disclosure of the study information

2026 Year 06 Month 15 Day


Related information

URL releasing protocol

NA

Publication of results

Unpublished


Result

URL related to results and publications

NA

Number of participants that the trial has enrolled

21

Results

Within each carbohydrate concentration condition (n = 12 each), participants consumed water, a sucrose-containing beverage, or an isomaltulose-containing beverage in a randomized crossover order. At a carbohydrate concentration of 6.5%, both sucrose- and isomaltulose-containing beverages reduced urine output and improved the beverage hydration index compared with water. In contrast, these fluid-retention effects were not observed at carbohydrate concentrations of 1.5% or 4.0%.

Results date posted

2026 Year 06 Month 15 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

21 healthy young adults participated in this study. Twelve participants completed each carbohydrate concentration condition, and some participants took part in more than one carbohydrate concentration condition. Because this study used a crossover design, participants were not assigned to fixed parallel groups.

Participant flow

21 healthy young adults participated in this study. Twelve participants completed each carbohydrate concentration condition. Within each concentration condition, participants completed three trials in a randomized crossover order: water, sucrose-containing beverage, and isomaltulose-containing beverage. Some participants took part in more than one carbohydrate concentration condition. All participants completed their assigned trials and were included in the analyses of the primary outcomes, urine output and beverage hydration index.

Adverse events

No serious adverse events or other adverse events related to the study were observed.

Outcome measures

The primary outcome measures were cumulative urine output and beverage hydration index (BHI) after beverage ingestion. The secondary outcome measures were blood glucose concentration, plasma insulin concentration, plasma osmolality, percent change in plasma volume, thirst, stomach fullness, hunger, and beverage palatability.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 09 Month 01 Day

Date of IRB

2023 Year 11 Month 06 Day

Anticipated trial start date

2023 Year 12 Month 01 Day

Last follow-up date

2024 Year 08 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 06 Month 15 Day

Last modified on

2026 Year 06 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070842